All publications

Export 167 results:
Author Title Type [ Year(Desc)]
2014
Mbisa JL, Fearnhill E, Dunn DT, Pillay D, Cane P A, UK HIV Drug Resistance Database.  2014.  Sustained Spread of HIV-1 Drug Resistance in Treatment-Naïve Patients in the United Kingdom. Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014.
Mourad R, Chevennet F, Dunn DT, Fearnhill E, Asboe D, Gascuel O, Hue S.  2014.  Transmission and persistence of antiretroviral resistance amongst drug naïve HIV positive individuals in the United Kingdom. International Workshop on Antiviral Drug Resistance, June 2014.
2015
Byrne L, Thorne C, Tookey P, Tostevin A, Dunn DT, Chau C, Delpech V.  2015.  Antiretroviral drug resistance in pregnant women living with HIV in England and Wales: Preliminary results from the matching of three national HIV surveillance databases. British HIV Association Conference (BHIVA) 2015.
Mbisa JL, Fearnhill E, Dunn DT, Pillay D, Asboe D, Cane P A.  2015.  Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom. Clin Infect Dis. 61:829-36.
White E, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2015.  Imputing viral subtype in time to virological failure analyses. International Workshop on HIV Observational Databases (IWHOD) 2015.
Smit E, White E, Clark D, Churchill D, Zhang H, Collins S, Pillay D, Tostevin A, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2015.  K65R detected more frequently in HIV-1 subtype C viruses at virological failure. International HIV Drug Resistance Workshop, 2015.
Smit E, White E, Clark D, Churchill D, Zhang H, Collins S, Pillay D, Tostevin A, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2015.  K65R detected more frequently in HIV-1 subtype C viruses at virological failure. Conference on Retroviruses and Opportunistic Infections (CROI) 2015.
Mourad R, Chevennet F, Dunn DT, Fearnhill E, Delpech V, Asboe D, Gascuel O, Hue S.  2015.  A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK. AIDS. 29:1917-25.
Tostevin A, White E, Croxford S, Delpech V, Williams I, Dunn DT, UK HIV Drug Resistance Database.  2015.  Trends in transmitted drug resistance to HIV-1 in the UK since 2010. British HIV Association Conference (BHIVA) 2015.
2016
Le Vu S, Ratmann O, Delpech V, Brown A, Gill NO, Tostevin A, Fraser C, Volz E.  2016.  Characterising HIV transmission risk factors using genetic source attribution and phylogenetic clustering. HIV Dynamics and Evolution Meeting 2016.
Ragonnet-Cronin M, Shilaih M, Günthard HF, Hodcroft E, Boni J, Fearnhill E, Dunn DT, Yerly S, Klimait T, Aubert V et al..  2016.  A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland. Sci Rep. 6
TenoRes Study Group.  2016.  Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis.
El-Bouzidi K, White E, Mbisa JL, Sabin CA, Phillips AN, Mackie N, Pozniak A, Tostevin A, Pillay D, Dunn DT et al..  2016.  HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK. J Antimicrob Chemother. 71(12)
Geretti AM, White E, Beloukas A, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin CA, Dunn DT et al..  2016.  Impact of Transmitted Thymidine Analogue Mutations on Responses to First-Line ART. International HIV Drug Resistance Workshop 2016.
Geretti AM, White E, Beloukas A, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin CA, Dunn DT et al..  2016.  Impact of Transmitted Thymidine Analogue Mutations on Responses to First-Line ART. Conference on Retroviruses and Opportunistic Infections (CROI) 2016.
De Luca A., Flandre P., Dunn DT, Zazzi M, Wensing A., Santoro MM, Günthard HF, Wittkop L., Kordossis T., Garcia F. et al..  2016.  Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen. J Antimicrob Chemother. 71:1352-60.
Antiretroviral Therapy Cohort Collaboration(ART-CC), Canadian Observational Cohort Collaboration(CANOC), UK Collaborative HIV Cohort Study(UK CHIC), Collaboration of Observational HIV Epidemiological Research in Europe(COHERE).  2016.  Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis. AIDS. 30(3)
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin CA, Pillay D, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2016.  No Effect of HIV-1 Subtype C on Virological Failure Rate with First-line TDF Regimens. International HIV Drug Resistance Workshop 2016.
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin CA, Pillay D, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2016.  No Effect of HIV-1 Subtype C on Virological Failure Rate with First-line TDF Regimens. Conference on Retroviruses and Opportunistic Infections (CROI) 2016.
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin CA, Pillay D, Dunn DT, UK HIV Drug Resistance Database et al..  2016.  No evidence that HIV-1 subtype C infection compromises the efficacy of Tenofovir-containing: Cohort study in the United Kingdom. J Infect Dis.